2025.03.03
Graph Therapeutics Awarded €1.1M “Austrian Life Sciences” FFG Grant
Graph has recieved grant funding from the Austrian Research Promotion Agency (FFG) to advance our clinically realistic precision immunology platform.
2025.01.09
Graph Therapeutics Raises $3.1M Pre-Seed Round to Transform Drug Discovery for Immunological Diseases
Veteran techbio team that pioneered AI-driven precision oncology reunites to tackle the critical and complex challenges of inflammatory and immunological diseases
